Clinical evaluation of a new sensitive calcitonin assay: study of specificity (Q44819471)

6 December 2017

title

Clinical evaluation of a new sensitive calcitonin assay: study of specificity (English)

1 reference

6 December 2017

M d'Herbomez

1

1 reference

6 December 2017

L Leclerc

2

1 reference

6 December 2017

M C Vantyghem

3

1 reference

6 December 2017

F Fourrier

4

1 reference

6 December 2017

C Proye

5

1 reference

6 December 2017

J L Wemeau

6

1 reference

6 December 2017

publication date

1 September 2001

1 reference

6 December 2017

1 reference

6 December 2017

volume

311

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

149-155

1 reference

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

THYROCALCITONIN: HYPOCALCEMIC HYPOPHOSPHATEMIC PRINCIPLE OF THE THYROID GLAND

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Immunochemical Heterogeneity of Calcitonin in Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Novel peptides from the calcitonin gene: expression, receptors and biological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Calcitonin: physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Increased serum and urinary calcitonin levels in patients with pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

High serum procalcitonin concentrations in patients with sepsis and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Procalcitonin increase after endotoxin injection in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Procalcitonin as a marker for the early diagnosis of neonatal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Procalcitonin--a new indicator of the systemic response to severe infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Serum procalcitonin levels in bacterial and abacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Pentagastrin testing in patients with renal insufficiency: normal responsivity of mature calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Procalcitonin (PCT) production in a thyroidectomized patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Molecular aspects and natural source of procalcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Procalcitonin: new insights on regulation and origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900582-4

10.1016/S0009-8981(01)00582-4

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference